AZN Operating Income Growth
AstraZeneca PLC Ordinary Shares · Operating Income Growth
AZN Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported23.38%period ending
AZN TTM Operating Income YoY % (41.48% → 23.38%)
Year-over-year change
High-resolution chart · PNG
AZN operating income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Income Growth |
|---|---|
| 23.3751% | |
| 35.533% | |
| 37.3888% | |
| 39.1262% | |
| 25.1409% | |
| 20.5845% | |
| 22.092% | |
| 14.2556% | |
| 23.2162% | |
| 61.3967% | |
| 118.131% | |
| 239.789% | |
| 1,437.7049% | |
| 13,815.3846% | |
| 255.6818% | |
| -16.4021% | |
| -109.6655% | |
| -99.3318% | |
| -79.5428% | |
| -33.3255% | |
| 47.9937% | |
| 91.5655% | |
| 76.539% | |
| 24.1822% | |
| 9.0961% | |
| -19.5618% | |
| -13.6699% | |
| 14.2857% | |
| 6.8002% | |
| 9.6065% | |
| -7.8869% | |
| -45.7639% | |
| -39.0339% | |
| -27.7139% | |
| -24.9898% | |
| 59.7917% | |
| 50.125% | |
| 13.3207% | |
| 19.1541% | |
| 29.1371% | |
| 75.7324% | |
| 88.8541% | |
| 92.5129% | |
| 41.2665% | |
| -33.0719% | |
| -29.1019% | |
| -42.43% | |
| -69.7622% | |
| -54.4439% | |
| -57.3324% | |
| -54.4428% | |
| -24.9551% | |
| -35.7655% | |
| -36.0827% | |
| -36.3189% | |
| -35.9537% | |
| -6.492% | |
| 2.684% | |
| 11.3189% | |
| 14.297% | |
| -8.3811% | |
| -6.4127% | |
| -0.4245% | |
| 2.6823% | |
| 17.0502% | |
| 19.6318% | |
| 26.2358% | |
| 21.0108% | |
| 20.1244% | |
| 22.8456% | |
| 12.9726% | |
| 12.4021% | |
| 5.1987% | |
| -2.7229% | |
| -1.4849% | |
| 4.0642% | |
| 10.9438% | |
| 19.7153% | |
| 26.3611% | |
| 312.021% | |
| 438.2055% | |
| 881.1453% | |
| 1,964.127% | |
| -53.8182% | |
| -65.8595% | |
| -81.5886% | |
| -92.3376% | |
| 3.3003% | |
| 6.566% | |
| -2.0338% | |
| 2.967% | |
| -33.1231% | |
| -37.5818% | |
| -33.4139% | |
| -29.8486% | |
| 54.6457% | |
| 61.6492% | |
| 56.8806% | |
| 55.2752% | |
| 52.396% |